Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 12Thoracic 11Gastrointestinal 11Other hematologic neoplasm 8Lymphoid 6Genitourinary 5Other solid neoplasm 4Gynecologic 4Other 3Plasma cell 2Head & Neck 2Other neoplasm 1Myeloid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Dyslipidemias 1Central Nervous System Neoplasms 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Exercise Test × CNS × Clear all
NCT05641636 2022-12-07

Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors

I.M. Sechenov First Moscow State Medical University

Completed
60 enrolled
CNS

Central Nervous System Neoplasms, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡